Moor Vascular Assessment System -

Moor 血管评估系统 -

基本信息

项目摘要

DESCRIPTION (provided by applicant): This proposal is for the purchase of a Moor Instruments Vascular Assessment System (VAS), which will serve 7 NIH-funded research groups. The VAS is an integrated laser Doppler imaging (LDI) device that will replace our first generation Moor LDI system, which has been working at near maximum capacity for 8 years, but is outdated and produces data of inferior quality due to the low resolution images generated. An additional limitation of the present system is the wavelength of the laser does not penetrate past the most superficial tissue layers and, therefore, does not adequately interrogate the areas of interest. Finally, the present modality does not allow real-time capture of images for determining transient changes in blood flow due to interventions. The demand for LDI on our campus continues to grow, and the proposed system will fulfill the needs of a large number of researchers by providing excellent resolution of vascular beds, allowing assessment of deep tissue microcirculatory systems and providing serial, non-invasive dynamic visualization and quantitation of blood flow, so that new applications for LDI can be accommodated or developed. The VAS can image specimens with very high resolution (less than 100 mm), penetrate up to 3 mm in depth and can capture up to 25 frames per second of video. A typical scan takes only about 15 minutes (including preparation of animal model), and the system comes with an analysis workstation to allow rapid quantitation. The enhanced capabilities of the system will better serve the needs of our vascular biology research community. Applications for the proposed facility include: 1) Assessment of stem cell-induced revascularization of ischemic tissues. 2) Stem and progenitor cell-mediated vasculogenesis in tissue and cell grafts. 3) Serial evaluation of tumor perfusion in response to anti-angiogenic agents 4) Involvement of a bone marrow-derived cell population in neovascularization. 5) Evaluate the contribution of different endothelial progenitor types in vascular remodeling and angiogenesis. 6) Determination of the molecular mechanisms that contribute to disease-associated attenuation of endothelial repair processes and vasoreactivity. The acquisition of the VAS is essential for continued progress on these and future projects requiring this state-of-the-art technology. PUBLIC HEALTH RELEVANCE: This proposal is for purchase of a new laser Doppler imaging system, which will be used to study biological specimens from several laboratories. This technology will make possible new discoveries in the areas of vascular disease, blood homeostasis, assess the activity of compounds that alter blood flow, vascular remodeling and arteriogenesis in normal and diseased tissues.
描述(由申请人提供):该提案用于购买摩尔工具的血管评估系统(VAS),该系统将服务于7个由NIH资助的研究小组。 VAS是一种集成的激光多普勒成像(LDI)设备,它将取代我们的第一代摩尔LDI系统,该系统已经运行了8年,但由于产生的低分辨率图像而产生了质量较低的数据。当前系统的另一个局限性是激光的波长不会超过最浅层组织层,因此不能充分询问感兴趣的区域。最后,目前的方式不允许实时捕获图像来确定干预措施引起的血流瞬态变化。 我们校园对LDI的需求不断增长,拟议的系统将通过提供出色的血管床的分辨率来满足大量研究人员的需求,从而评估深层组织微循环系统,并提供连续的,无创的动态可视化和血液流动的定量,以适应​​LDI的新应用,从而容纳或已开发或已开发或已开发或开发。 VAS可以以很高的分辨率(小于100毫米)的形象成像标本,深度高达3毫米,并且可以捕获视频的每秒25帧。典型的扫描仅需大约15分钟(包括动物模型的制备),并且该系统具有分析工作站以允许快速定量。该系统的增强功能将更好地满足我们血管生物学研究界的需求。建议的设施的应用包括:1)评估干细胞诱导的缺血组织血运重建。 2)在组织和细胞移植物中的茎和祖细胞介导的血管生成。 3)响应抗血管生成剂的肿瘤灌注的序列评估4)骨髓来源的细胞群参与新血管形成。 5)评估不同内皮祖细胞类型在血管重塑和血管生成中的贡献。 6)确定有助于疾病相关的内皮修复过程衰减和血管反应性的分子机制。 对VA的收购对于需要这种最先进技术的这些和未来的项目的持续进展至关重要。 公共卫生相关性:该建议是用于购买新的激光多普勒成像系统,该系统将用于研究来自几个实验室的生物标本。这项技术将使血管疾病,血液稳态,评估改变血液流动,正常和患病组织中的血管重塑和动脉生成的化合物的活性成为可能的新发现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian H. Johnstone其他文献

Novel strategies for storage and recovery of cadaveric bone marrow stem cells
  • DOI:
    10.1016/j.cryobiol.2018.10.146
  • 发表时间:
    2018-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Aubrey M. Sherry;Brian H. Johnstone;Steven Messina-Graham;Erik J. Woods
  • 通讯作者:
    Erik J. Woods

Brian H. Johnstone的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian H. Johnstone', 18)}}的其他基金

A Novel and Clinically Feasible Co-therapy of Deceased Donor Bone Marrow Combined With Donor-Matched Mesenchymal Stem Cells to Establish Immune Tolerance
一种新颖且临床可行的联合疗法,将已故供体骨髓与供体匹配的间充质干细胞相结合,以建立免疫耐受
  • 批准号:
    10081139
  • 财政年份:
    2020
  • 资助金额:
    $ 13.04万
  • 项目类别:
Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury
开发纯化的骨髓祖细胞库作为放射损伤引起的短暂性全血细胞减少症的桥接疗法
  • 批准号:
    10081134
  • 财政年份:
    2020
  • 资助金额:
    $ 13.04万
  • 项目类别:
A Novel and Clinically Feasible Co-therapy of Deceased Donor Bone Marrow Combined With Donor-Matched Mesenchymal Stem Cells to Establish Immune Tolerance
一种新颖且临床可行的联合疗法,将已故供体骨髓与供体匹配的间充质干细胞相结合,以建立免疫耐受
  • 批准号:
    10212956
  • 财政年份:
    2020
  • 资助金额:
    $ 13.04万
  • 项目类别:
Validation of a Stroke Therapy Comprised of Synergistic Stem Cell-Derived Factors
包含协同干细胞衍生因子的中风疗法的验证
  • 批准号:
    8980800
  • 财政年份:
    2015
  • 资助金额:
    $ 13.04万
  • 项目类别:

相似国自然基金

髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
  • 批准号:
    82372496
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
  • 批准号:
    82300396
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
  • 批准号:
    32370568
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
  • 批准号:
    82360332
  • 批准年份:
    2023
  • 资助金额:
    31.00 万元
  • 项目类别:
    地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
  • 批准号:
    82303057
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

First-in-class TREM-1 inhibitors for neovascular retinal diseases
用于治疗新生血管性视网膜疾病的一流 TREM-1 抑制剂
  • 批准号:
    10597284
  • 财政年份:
    2023
  • 资助金额:
    $ 13.04万
  • 项目类别:
Extracellular Matrix Impacts Angiogenesis and Growth Plate Repair
细胞外基质影响血管生成和生长板修复
  • 批准号:
    10668056
  • 财政年份:
    2023
  • 资助金额:
    $ 13.04万
  • 项目类别:
Fibrin-CAR-T cells therapies to enhance efficacy in glioblastoma treatments
纤维蛋白-CAR-T 细胞疗法可增强胶质母细胞瘤治疗的疗效
  • 批准号:
    10515887
  • 财政年份:
    2022
  • 资助金额:
    $ 13.04万
  • 项目类别:
Elucidation of novel anti-angiogenic therapies for the prevention and treatment of neovascular glaucoma
阐明预防和治疗新生血管性青光眼的新型抗血管生成疗法
  • 批准号:
    10491662
  • 财政年份:
    2021
  • 资助金额:
    $ 13.04万
  • 项目类别:
Mechanisms of post-preeclampsia hypertension
子痫前期高血压的机制
  • 批准号:
    10541890
  • 财政年份:
    2021
  • 资助金额:
    $ 13.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了